-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Neutral on Zimmer Biomet Holdings, Raises Price Target to $117

Benzinga·11/05/2026 22:08:41
Listen to the news
Citigroup analyst Joanne Wuensch maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Neutral and raises the price target from $99 to $117.